<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02731430</url>
  </required_header>
  <id_info>
    <org_study_id>274</org_study_id>
    <nct_id>NCT02731430</nct_id>
  </id_info>
  <brief_title>Intrathecal Morphine for Postoperative Analgesia Following Laparoscopic Bariatric Surgery</brief_title>
  <official_title>Intrathecal Morphine for Postoperative Pain Management in Patients Undergoing Laparoscopic Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      this study compares the use of intrathecal morphine, to multimodal analgesic techniques for
      postoperative pain management following laparoscopic bariatric surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total postoperative analgesic consumption.</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>the efficacy of the studied dose of intrathecal morphine in reducing postoperative analgesic consumption.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analogue scale (VAS) scores</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>postoperative pain scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first request of rescue analgesia.</measure>
    <time_frame>24 hours postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerability as assessed by the incidence of side effects</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>the incidence of side effects</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>group I: morphine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>received 0.3mg morphine (0.3ml) added to 1.2ml of bupivacaine 0.5% (total volume 1.5ml), intrathecally, immediately before induction of general anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group II: control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>received 0.3ml saline added to 1.2mlof bupivacaine 0.5% (total volume 1.5ml), intrathecally, immediately before induction of general anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intrathecal morphine</intervention_name>
    <description>received 0.3mg morphine (0.3ml) added to 1.2ml of bupivacaine 0.5% (total volume 1.5ml), intrathecally, immediately before induction of general anesthesia.</description>
    <arm_group_label>group I: morphine group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intrathecal saline</intervention_name>
    <description>received 0.3ml saline added to 1.2mlof bupivacaine 0.5% (total volume 1.5ml), intrathecally, immediately before induction of general anesthesia.</description>
    <arm_group_label>group II: control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesia (ASA) II-III patients.

          -  Aged 30-50 years.

          -  The body mass index (BMI) of the patients needed to be over 40 kg/m² or over 35 kg/m²
             with at least one comorbidity.

        Exclusion Criteria:

          -  Patients with a known allergy to the study drugs.

          -  Advanced cardiac, respiratory, renal or hepatic disease.

          -  Coagulation disorders.

          -  Infection at or near the site of intrathecal injection.

          -  Drug or alcohol abuse.

          -  Psychiatric illnesses that may interfere with perception and assessment of pain.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 3, 2016</study_first_submitted>
  <study_first_submitted_qc>April 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2016</study_first_posted>
  <last_update_submitted>April 6, 2016</last_update_submitted>
  <last_update_submitted_qc>April 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmad Mohammad Abd El-Rahman</investigator_full_name>
    <investigator_title>Lecturer of anesthesia, icu, and pain management</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

